Verve Therapeutics Income Statement

Financials in millions IDR. Fiscal year is January - December.

Millions IDR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	8,046	7,072	5,740	4,033	3,538
Revenue Growth (YoY)	13.78%	23.21%	42.32%	13.99%	-
Cost of Revenue	3,037	2,896	2,465	1,907	1,517
Gross Profit	5,009	4,176	3,275	2,126	2,021
Selling, General & Admin	4,270	2,526	2,161	1,496	1,459
Other Operating Expenses	192.91	229.6	62.78	11.73	15.47
Operating Expenses	4,463	2,756	2,224	1,508	1,475
Operating Income	545.92	1,420	1,051	617.7	546.42
Interest Expense	-43.9	-95.14	-	-	-
Interest & Investment Income	132.55	59.38	2.86	6.15	3.99
Currency Exchange Gain (Loss)	-	-80.68	-10.78	-	-
Other Non Operating Income (Expenses)	-15.23	72.5	0.26	-1.07	-10.67
EBT Excluding Unusual Items	619.34	1,376	1,043	622.78	539.74
Asset Writedown	-	-	-31.95	-	-
Pretax Income	619.34	1,376	1,011	622.78	539.74
Income Tax Expense	208.76	81.66	136.88	20.16	17.69
Net Income	410.58	1,295	874.26	602.62	522.05
Net Income to Common	410.58	1,295	874.26	602.62	522.05
Net Income Growth	-68.29%	48.10%	45.08%	15.43%	-
Shares Outstanding (Basic)	1,434	1,434	567	100	-
Shares Outstanding (Diluted)	1,434	1,434	567	100	-
Shares Change (YoY)	0.00%	153.03%	466.75%	-	-
EPS (Basic)	0.29	0.90	1.54	6.03	-
EPS (Diluted)	0.29	0.90	1.54	6.03	-
EPS Growth	-68.29%	-41.47%	-74.40%	-	-
Free Cash Flow	-10,723	-14,506	-3,302	-64.84	-101.5
Free Cash Flow Per Share	-7.48	-10.12	-5.83	-0.65	-
Gross Margin	62.25%	59.05%	57.06%	52.71%	57.13%
Operating Margin	6.78%	20.09%	18.31%	15.32%	15.45%
Profit Margin	5.10%	18.31%	15.23%	14.94%	14.76%
Free Cash Flow Margin	-133.27%	-205.12%	-57.53%	-1.61%	-2.87%
EBITDA	1,416	1,512	1,433	684.78	1,173
EBITDA Margin	17.59%	21.38%	24.98%	16.98%	33.15%
D&A For EBITDA	869.58	91.32	382.72	67.08	626.23
EBIT	545.92	1,420	1,051	617.7	546.42
EBIT Margin	6.78%	20.09%	18.31%	15.32%	15.45%
Effective Tax Rate	33.71%	5.93%	13.54%	3.24%	3.28%
Advertising Expenses	16.85	1.5	38.4	27.62	14.88

Updated Oct 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.